1. Home
  2. UPC vs EOCN Comparison

UPC vs EOCN Comparison

Compare UPC & EOCN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Universe Pharmaceuticals Inc.

UPC

Universe Pharmaceuticals Inc.

N/A

Current Price

$4.10

Market Cap

3.3M

Sector

Health Care

ML Signal

N/A

EOCN

Eocene Ltd. Ordinary Shares

N/A

Current Price

$3.42

Market Cap

3.6M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
UPC
EOCN
Founded
1998
2000
Country
China
Israel
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.3M
3.6M
IPO Year
2020
2013

Fundamental Metrics

Financial Performance
Metric
UPC
EOCN
Price
$4.10
$3.42
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
★ 51.7K
5.7K
Earning Date
01-29-2026
11-25-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$2.00
$3.12
52 Week High
$17.96
$3.80

Technical Indicators

Market Signals
Indicator
UPC
EOCN
Relative Strength Index (RSI) 40.95 54.84
Support Level $3.77 $3.12
Resistance Level $5.00 $3.80
Average True Range (ATR) 0.33 0.23
MACD -0.04 -0.00
Stochastic Oscillator 9.71 57.36

Price Performance

Historical Comparison
UPC
EOCN

About UPC Universe Pharmaceuticals Inc.

Universe Pharmaceuticals Inc is a pharmaceutical company specializing in the manufacturing, marketing, sales and distribution of traditional Chinese medicine derivatives products targeting the elderly with the goal of addressing their physical conditions in the ageing process and promoting their general well-being. The company also sells biomedical drugs, medical instruments, Traditional Chinese Medicine Pieces, and dietary supplements manufactured by third-party pharmaceutical companies. Its products are under two categories namely treatment and relief for common chronic health conditions in the elderly designed to achieve physical wellness and longevity (Chronic Condition Treatments), and cold and flu medications.

About EOCN Eocene Ltd. Ordinary Shares

Eocene Ltd is a GI-focused medtech and biopharmaceutical company focused on advancing solutions across gastrointestinal disease management, GI oncology and related therapeutic areas. Its wholly owned subsidiary develops medical devices for postoperative colorectal care, including CG-100, an intraluminal bypass device intended to protect colorectal anastomoses and reduce the need for diverting stomas. The company's therapeutic portfolio includes Aramchol, a first-in-class synthetic fatty acid-bile acid conjugate molecule being evaluated in liver disease and oncology indications, including gastrointestinal cancers.

Share on Social Networks: